Philip Morris
the Carcinogenicity of Fibrous Minerals
Fields
- Author
- Layard, M.
- Stanton, M.F.
- Type
- SCRT, REPORT, SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- LIST, LIST
- ABST, ABSTRACT
- Area
- SOLANA,RICHARD/CENTRAL FILES
- Litigation
- Fali/Produced
- Characteristic
- EXTR, EXTRA
- Site
- R545
- Named Organization
- Natl Bureau of Standards
- OSHA, Occupational Safety & Health Administration
- Unio Internationale Contra Cancer Work G
- Workshop on Asbestos
- OSHA, Occupational Safety & Health Administration
- Author (Organization)
- NCI, Natl Cancer Inst
- NIH, Natl Inst of Health
- Public Health Service
- Hew, Dept of Health Education and Welfare
- Biometry Branch
- Lab of Pathology
- NIH, Natl Inst of Health
- Named Person
- Kotin, P.
- Langer, A.
- Smith, W.
- Stanton, M.F.
- Sundaram, A.
- Wagner
- Warren, J.
- Langer, A.
- Master ID
- 2063104795/5283
Related Documents:- 2063104795-5283 Proceedings of Workshop on Asbestos: Definitions and Measurement Methods Proceedings of A Workshop on Asbestos Held at the National Bureau of Standards, Gaithersburg, Maryland, 770718 - 770720
- 2063104803-4820 History of Asbestos - Related Mineralogical Terminology
- 2063104821-4835 Fibrous and Asbestiform Minerals
- 2063104836-4849 the Crystal Structures of Amphibole and Serpentine Minerals
- 2063104850-4864 the 'asbestos' Minerals: Definitions, Description, Modes of Formation, Physical and Chemical Properties, and Health Risk to the Mining Community
- 2063104865-4870 General Discussion of Mineralogical Aspects
- 2063104871-4893 Epidemiological Evidence on Asbestos
- 2063104894-4918 Measurement of Asbestos Retention in the Human Respiratory System Related to Health Effects
- 2063104919-4930 Epidemiologic Evidence of the Effect of Type of Asbestos and Fiber Dimensions on the Production of Disease in Man
- 2063104931-4940 Pathophysiology in Relation to the Chemical and Physical Properties of Fibers
- 2063104950-4958 Niehs Oral Asbestos Studies
- 2063104959-4973 Epa Study of Biological Effects of Asbestos - Like Mineral Fibers
- 2063104974-4985 A Study of Airborne Asbestos Fibers in Connecticut
- 2063104986-4995 General Discussion of Relationship Between Chemical and Physical Properties and Health Effects
- 2063104996-5015 Identification of Selected Silicate Minerals and Their Asbestiform Varieties
- 2063105016-5029 An Overview of Electron Microscopy Methods
- 2063105030-5043 Identification of Asbestos by Polarized Light Microscopy
- 2063105044-5064 Mineral Fiber Identification Using the Analytical Transmission Electron Microscope
- 2063105065-5074 Transmission Electron Microscopical Methods for the Determination of Asbestos
- 2063105075-5088 Statistics and the Significance of Asbestos Fiber Analyses
- 2063105089-5106 Selection and Characterization of Fibrous and Nonfibrous Amphiboles for Analytical Methods Development
- 2063105107-5117 Asbestiform Minerals in Industrial Talcs: Commercial Definitions Versus Industrial Hygiene Reality
- 2063105118-5131 the Detection and Identification of Asbestos and Asbestiform Minerals in Talc
- 2063105132-5146 Misidentification of Asbestos in Talc
- 2063105147-5155 Ambient Air Monitoring for Chrysotile in the United States
- 2063105156-5167 Environmental Protection Agency Interim Method for Determining Asbestos in Water
- 2063105168-5171 Inter-Laboratory Measurements of Amphibole and Chrysotile Fiber Concentration in Water
- 2063105172-5177 the Standard for Occupational Exposure to Asbestos Being Considered by Astm Committee E-34
- 2063105178-5193 Identification and Counting of Mineral Fragments
- 2063105194-5202 Practical Aspects of Talc and Asbestos
- 2063105203-5210 General Discussion of Analytical Methods
- 2063105211 Introduction
- 2063105212-5219 the Mining Enforcement and Safety Administration - Regulations and Methods
- 2063105220-5229 Occupational Safety and Health Administration Methods
- 2063105230-5236 FDA Projects and Methods
- 2063105237-5238 Cosmetic Talc Powder
- 2063105239-5248 Cpsc Regulation of Non-Occupational Exposure to Asbestos in Consumer Products
- 2063105249-5255 Impact of Asbestos Regulations on the Mining Industry
- 2063105256-5265 General Discussion of Regulatory Aspects
- Date Loaded
- 20 Sep 1999
- UCSF Legacy ID
- jbp52d00
Document Images
CS
National Bureau of Standards Special Publication 506. Proceedings of the Workshop on
Asbestos: Definitions and Measurement Methods held at NBS, Gaithersburg, MD, July 18-20,
1977. (Issued November 1978)
THE CARCINOGENICITY OF FIBROUS MINERALS
Mearl F. Stanton
Laboratory of Pathology
and
Maxwell Layard
Biometry Branch
National Cancer Institute
National Institutes of Health
Public Health Service
Department of Health, Education, and Welfare
Bethesda, Maryland 20014
Abstract
The carcinogenicities of 37 different dimensional distributions of
seven different durable fibrous materials were correlated with fiber
dimension. Optimum correlation was attained with fibers that measured
<0.25 pm x >8 pm. Morphologic studies suggested that fibers in this
dimensional range lie free in interstitial tissues, while fibers of
smaller dimension are readily phagocytosed and fibers of larger
dimension are sequestered by adherent phagocytes and fused phagocytic
giant cells. Fibers that are fine and long may be more carcinogenic than
others, simply because they are uncompromised by phagocytic activity.
Keywords: Aluminum oxide; asbestos; carcinogenicity; Dawsonite; fibers;
fibrous glass; phagocytosis; potassium octatitanate.
For the past several years we have been interested in the question of how asbestos
causes cancer once a fiber reaches susceptible tissues. We have approached t;~s problem
with the simple device of introducing various types of particles into the pleural space
of rats and observing the resultant tumors during the subsequent two years. The methods
that we have used can be summarized briefly [1,2,37.1 A standard 40 mg dose of particles
is applied by open thoracotomy directly to the left pleural surface of young female
Osborne-Mendel rats. In each experiment, 30 to 50 rats are followed for two years and
those surviving at two years are killed. All rats are necropsied and all pathological
lesions examined histologically. Tumors that resemble the mesenchymal mesotheliomas of man
generally develop after the first year. For the sake of precision we have called these
tumors pleural sarcomas. During the second year, rats die at various times with and
without pleural sarcomas; consequently, we have used actuarial computation to arrive at a
valid estimate of the incidence of pleural sarcomas which takes into account differences in
life-span [4]. Probability of pleural sarcoma has ranged from 0 to 100 percent depending
on the materials used. Pleural sarcomas have not been observed in several thousand
untreated controls; however, pleural sarcomas have occurred in rats treated only by
simple thoracotomy. Our best estimate of these non-specific, background pleural sarcomas
in treated controls is In the range of 2-4 percent. This is important to keep in mind
since it makes interpretation of low level response unreliable with small numbers of
animals.
'Figures in brackets indicate the literature references at the end of this paper.
143

There are two separate features of asbestos particles that merit consideration as
potentially carcinogenic. First, the chemical nature of their constituents and contami-
nents, especially those with a known potential for carcinogenicity such as the polycyclic
hydrocarbons and heavy metals. Secondly, the physical structure of asbestos particles
which in their fibrous fineness are somewhat unique in the natural world. It is our
contention that it is the latter property, namely the simple quality of being an excep-
tionally fine, long, durable fiber, that is most critical to carcinogenicity. The sup-
porting evidence for this hypothesis is derived primarily from the type of experiments
described above, as carried out by us and others [1,2,3,5,6,7]. It can be summarized
briefly as follows:
(1) Vigorous extraction of natural and contaminating hydrocarbons from asbestos does not
alter its carcinogenicity.
(2) Hand-cobbed, hand-milled asbestos that is free of metallic mill contamination is no
less carcinogenic than machine-milled asbestos.
(3) Naturally occurring or contaminating carcinogenic metals such as nickel, cobalt,
chromium, iron, magnesium, and silica, or hydrocarbons such as benzo(a)pyrene, of
comparable quantity to that in asbestos, when attached to inert non-fibrous particles
of a size comparable to asbestos, do not show the carcinogenicity of asbestos.
(4) The carcinogenicity of asbestos is greatly reduced if implanted as whole unseparated
sheets of fibers or implanted as very short submicroscopic fibrils.
(5) The carcinogenicity of asbestos is greatly reduced if asbestos is heated sufficiently
to increase its fragility or if pulverized to non-fibrous particles.
(6) Finally, between the various types of asbestos, particularly crocidolite, amosite,
tremolite, anthophyllite, and chrysotile, there are wide variations in chemical,
crystalline, and molecular structure. Nevertheless, when similar dimensional distri-
butions of these asbestoses are applied directly to the pleura their carcinogenic
response is similar_
If the carcinogenicity of asbestos depends on its dimensional configuration, two
corollary hypotheses are suggested. First, durable fibers of other materials if in the
same dimensional range as asbestos should be as carcinogenic as asbestos. Secondly, there
should be an optimal dimensional range of fibers relevant to carcinogenicity.
The data which I would like to present today relates to these two corollaries.
Table 1 lists 37 experiments with seven different durable fibrous materials, each of
differing dimensional distributions, but at or near the size distribution of asbestos. We
have listed these in order of their probability of inducing pleural sarcomas, and as you
can see the range runs the gamut from 0 to 100 percent. Asbestos fibers of a standard size
characterized by a working group of the Unio Internationale contra Cancer would fall in
the range of 65-80 percent [8].
The problem that follows is that of determining the dimensional distribution of the
particles in each sample. To do this we used the straightforward method of measuring
length and diameter from montage photographs of typical samples of the particles implanted.
A minimum of 1000 particles were tabulated at magnification of 3000X to 29,000X. Subse-
quently, in samples containing large particles, magnifications of 1000X were used to
tabulate fibers inadequately represented on electron micrograph grids. The proper ratio
of microscopic to submicroscopic particles yielded a representative sum of measured
particles which was then entered into an IBM System 370 computer. From the density and
the sum of the calculated volumes, the weight of the counted samples could be obtained and
the distribution of particles per microgram of the sample estimated. For convenience, the
numbers of particles per microgram were grouped into 34 dimensional ranges as indicated in
Table 2. Table 2 illustrates the tabulation of six of the experiments with different
samples of glass. By simple inspection the six examples show an apparent relationship
between tumor probability and particle distribution that has held for all of the fibers
tested thus far. The examples suggest that particles in relatively thin (diameter
<0.25 pm) and long (length >8 }rm) dimensional categories are associated with the higher
tumor probabilities.
144

Y l\ i [W
\r!
Table 1. Cumulative list of experiments arranged by percent
probability of pleural sarcoma.
Percent
1. DIHYDROXY SODIUM ALUMINUM CARBONATE V. . . . . . . . . . 100
2. POTASSIUM OCTATITANATE I . . . . . . . . . . . . . . . 100
3. POTASSIUM OCTATITANATE II . . . . . . . . . . . . . . . . 100
4. SILICON CARBIDE GTC #1 . . . . . . . . . . . . . . . . . 100
5. DIHYDROXY SODIUM ALUMINUM CARBONATE I. . . . . . . . . . 95
6. BOROSILICATE GLASS (MOL) . . . . . . . . . . . . . . . . 85
7. BOROSILICATE GLASS (M6D) . . . . . . . . . . . . . . . . 77
8. BOROSILICATE GLASS + BINDER (KL) . . . . . . . . . . . . 74
9. BOROSILICATE GLASS (M6L) . . . . . . . . . . . . . . . . 72
10. ALUMINUM OXIDE -HC . . . . . . . . . . . . . . . . . . . 70
11. BOROSILICATE GLASS + BINDER (KW) . . . . . . . . . . . . 69
12. DIHYDROXY SODIUM ALUMINUM CARBONATE VII. ........ 68
13. DIHYDROXY SODIUM ALUMINUM CARBONATE IV .....'. ... 66
14. DIHYDROXY SODIUM ALUMINUM CARBONATE III. ........ 66
15. BOROSILICATE GLASS (M6W) . . . . . . . . . . . . . . . . 64
16. ALUMINUM OXIDE M3 . . . . . . . . . . . . . . . . . . . . 44
17. ALUMINUM OXIDE #4a . . . . . . . . . . . . . . . . . . . 41
18. ALUMINUM NITRIDE + OXIDE #6a . . . . . . . . . . . . . . 28
19. ALUMINUM OXIDE k2 . . . . . . . . . . . . . . . . . . . . 22
20. BOROSILICATE GLASS + BINDER (KCP). . . . . . . . . . . . 21
21. BOROSILICATE GLASS - BINDER (KUP). . . . . . . . . . . . 19
22. BOROSILICATE GLASS (MBL) . . . . . . . . . . . . . . 14
23. ALUMINUM OXIDE N4 . . . . . . . . . . . . . . . . . . . . 13
24. DIHYDROXY SODIUM ALUMINUM CARBONATE VI . . . . . . . . . 13
25. DIHYDROXY SODIUM ALUMINUM CARBONATE II . . . . . . . . . 12
26. BOROSILICATE GLASS (MOS) . . . . . . . . . . . . . . . . 8
27. BOROSILICATE GLASS + BINDER (K2P). . . . . . . . . . . . 8
28. MINERAL WOOL (Hi-Ca, Mg)(02P) . . . . . . . . . . . . . . 7
29. BOROSILICATE GLASS + BINDER (KFP). . . . . . . . . . . . 6
30. BOROSILICATE GLASS + BINDER (Y2P). . . . . . . . . . . . 6
31. HIGH CA-NA (P2P) . . . . . . . . . . . . . . . . . . . . 6
32. BOROSILICATE GLASS (M8S) . . . . . . . . . . . . . . . . 5
33. ALUMINUM OXIDE M5 . . . . . . . . . . . . . . . . . . . . 5
34. ALUMINUM OXIDE-LC (non-fibrous) . . . . . . . . . . . . . 3
35. BOROSILICATE GLASS (YW) (vehicle) (n=270). . . . . . . . 2
36. BOROSILICATE GLASS (M6S) . . . . . . . . . . . . . . . . 0
37. NI CKEL TITANATE . . . . . . . . . . . . . . . . . . . . . 0
145 N
0
a
w
r+
~
~
a.
w

4
C
Table 2. Six example experiments illustrating fiber distribution into 34
dimensional categories by comnon log of the number of particles
per microgram in each size category.
MOL KI
85.3% 73.9%
>0.8
>4.0-8.0 0.67
>2.5-4.0 0.67 1.52 0.97
>1.5-2.5 1.45 0.67 2.03 2.19
>.50-1.5 2.23 2.53 3.23 3.08 2.95 2.40 3.42 2.74
>.25-.50 3.08 3.95 2.55 3.16 3.63
>.10-.25 2.93 3.35 4.53 3.03 3.16 3.33 3.03
>.05-.10 3.93 4.79 2.85 4.09 3.76 3.25
.01-.05 3.46 4.65 3.03 3.73 3.03 3.03
CP M
K BL
21.5% 14.3%
>8.0 . 0.97
>4.0-8.0 1.81 2.01 1.81 0.17
>2.5-4.0 1.44 2.05 1.81 0.77 1.73 2.02
>1.5-2.5 2.05 2.17 2.31 0.97 1.49 1.12 2.11 2.27
>.50-1.5 3.00 3.59 3.17 2.85 2.01 2.60 1.45 2.35 2.42
>.25-.50 3.24 3.38 3.10 2.55 1.85 2.38
>.10-.25 3.24 3.28 3.10 2.50 1.85
>.05.-.10 2.50 2.90 1.85
.01-.05 2.20 2.98 2.67
MOS YW
8.3% 2.8%
>8.0 0.89 0.34
>4.0-8.0 2.46 2.72 0.92 0.40
>2.5-4.0 2.97 2.99 1.76 0.80 0.30
>1.5-2.5 3.43 2.37 1.17 T.00 0.11
>.50-1.5 3.88 3.91 2.76 2.46 T.10 0.41
>.25-.50 4.34 4.02 3.69 3.37
>.10-.25 4.43 3.88
>.05-.10 5.90 4.19
.01-.05 6.77 4.63
.01-1 >1-4 >4.8 >8-64 >64 .01-1 >1.4 >4.8 >8-64 >64
Length um
Diameter um
146

<0.25 E,m) and long (length >8 pm) dimensional categories are associated with the higher
tumor probabilities.
Statistical regression techniques afford a method of analysis that can use a
variety of explanatory variables to determine the best correlations between tumor
probability and size distribution. The logit transformation [9] was applied to the
estimated tumor probabilities (p) according to the formula:
logit - log W-5
Then, linear regression methods which find the best fitting function of the form
logit = a + blxl+....bkxk
were used to compare the common logarithm of the number of particles per microgram in
various size categories to the probability of pleural sarcoma. After analyzing various
dimensional ranges that might have narrowed the optimum tumor inducing size range, it
was determined that the best fit was with the dimensions <0.25 pm x >8 pm. The estimated
regression equation was:
logit = log (Q, _ -1.31 + .424x
with a correlation coefficient of 0.9. The regression curve for this dimensional range is
illustrated in figure 1. Figure 1 also indicates clearly that none of the seven different
types of fibers show consistently greater deviations from the curve than any othbr, and
that the curve's steepest slope is between 3-4 log particles per microgram. There was no
correlation with particles less than 8 pm in length, but relatively good correlatiohs were
also noted with numbers of fibers >8 pm in length and up to 1.5 vm in diameter (correlation
coefficient 0.52 to 0.74). Figure 2 illustrates the 34 parameters used for carcinogenicity
correlation and those categories in which relatively good correlation was obtained. It
should be remembered that absence of correlation does not preclude a low level of tumor
response outside these ranges.
Histologic observations suggest the reason for the difference in response to fine,
long fibers and those fibers that are either very short or very thick. The lesions in
those experiments with a low probability of pleural sarcoma were highly cellular, being
composed primarily of fibroblast-laden vascular granulation tissue with a relatively low
collagen content and an abundance of macrophages. In lesions from low tumor probability
groups in which virtually all fibers were less than 10 pm in length, the fibers seemed
completely contained within macrophages. On the other hand, in those lesions from low
tumor probability groups in which the fibers were virtually all of large diameter, the
fibers seemed sequestered from adjacent tissue by both macrophages and multinucleated
giant cells that closely invested the fiber surface. In contrast, the high tumor proba-
bility lesions were relatively acellular, with an abundance of collagen at the site of
implantation and the fine long fibers lay free in the interstitial tissues unaffected by
phagocytes. In ancillary experiments with non-fibrous particles that stimulate collagen
such as talc, silica, or carrageenin, collagen deposition equal to that of the high tumor
probability lesion has been observed without the subsequent development of tumors. There-
fore it seems evident that collagen itself is oot the critical factor in carcinogenesis.
However, the fact that the fine, long fibers were unaffected by phagocytic activity in the
high tumor probability groups suggests that fibers that are fine and long may be more
carcinogenic than others simply because they are uncompromised by phagocytic activity.
N
~
W
147 0
A
b
a
ue

C~b
0
0
1 2 4 8 6
LOG NUMBER PARTICUES /MICROGRAM
. ~ SIC
~ GLASS
. AL2o2
o ~ DAWSONITE
o - POTASSIUM OCTATfTANATE
- NICKEL TfTANATE
PARTICLE SIZE, -5 026 {m x >8 Nn CORRELATION . 0$
COEFFICIENT
Figure 1. Regression curve relating tumor probability to the comnon
logarithm of the number of particles per microgram with
diameters <0.25 um and lengths >8 pm.
148

~
»r~
Figure 2. Graphic display of the 34 size categories in scale with phagocytic and
mesothelial cells. The starred fibers are those that correlate with
pleural sarcoma probability.
149

cd
References
[1] Stanton, M. F., Layard, M., Tegeris, A., Miller, E., May, M., and Kent, E.,
Carcinogenicity of fibrous glass: Pleural response in the rat in relation to fiber
dimension, J. Natl. Cancer Inst. 58, 587-603 (1977).
[2] Stanton, M. F. and Wrench, C., Mechanisms of mesothelioma induction with asbestos and
fibrous glass, J. Natl. Cancer Inst. 48, 797-821 (1972).
[3] Stanton, M. F., Some etiological considerations of fibre carcinogenesis in Biolo ical
Effects of Asbestos (Bogovski, P., Timbrell, V., Gilson, J., et al. , e3s. . yon,
rance, t~orjT-FleaTth Organization, International Agency for Research on Cancer,
Publication No. 8, 1973, pp. 289-294.
[4] Armitage, P., Statistical Methods in Medical Research, New York, John Wiley & Sons,
1971, pp. 376-377, 410-414.
[5] Wagner, J. C., The pathogenesis of tumors following the intra pleural injection of
asbestos and silica in Mor of Ex er_ _ Res ratory Carcina enesis
(Nettesheim, P., Hanna~, M.-G-De-atherage, J W, eds.) Oak Ri ge ationa
Laboratory, Oak Ridge, Tennessee, Atomic Energy Commission Symposium Series No. 21,
1970, pp. 347-358.
[6] Smith, W. E., Miller, L., and Elasser, R. E., Tests for carcinogenicity of asbestos,
Ann. N.Y. Acad. Sci. 132, 456-488 (1965).
[7] Timbrell, V., Physical factors as etiological mechanisms in Biolo ical Effects of
Asbestos (Bogovski, P., Timbrell, V., Gilson, J. C., et aT-, e s. yon, irance,
or dealth Organization, International Agency for Research on Cancer, Publication
No. 8, 1973, pp. 295-303.
[8] Timbrell, V., Gilson, J. C., Webster, I., UICC standard reference samples of asbestos,
Int. J. Cancer 3, 406-408 (1968).
[9] Cox, 0., Regression models and life tables, J. R. Stat. Soc. r6 34, 187-220 (1972).
Discussion
A. SUNDARAM: These pleural sarcomas, are they localized? If you leave them for a
duration of time do they metastasize?
M. STANTON: Yes, this is real cancer, but they do not metastasize early.
A. LANGER: You allow your animals to live only two years, whereas Wagner allows his
rats to live three years. Have you had any control groups run for the duration of the
animals' lives? In those animals which you are reporting here, you are reporting frank
malignancy? How many of the other animals had hyperplastic lesions?
STANTON: It is difficult to detect precancerous lesions in mesenchymal tissues, so
that It really is difficult to say what might be precancerous. We find that after two
years plus the twenty weeks the animal has aged by the time we treat them, most rats are
in their terminal stages. These rats do not have normal lung capacity and so they do not
survive as long as the untreated rat does. By the end of the two years there is only a
small percentage of the rats left.
P. KOTIN: This business of assuming that hyperplasia carries with it as a corollary,
or is even indicative of subsequent malignant transformation or neoplasia, particularly in
mesenchymal tissue, has no substance at all. Now I am speaking as a pathologist. The
other thing is, there is a tendency to denigrate experiments which are terminated for the
reasons you said, when in fact the confounding findings which arise in the last six to
eight months of a rat or any experimental animals, are such as to muddy up the results.
I'd like your comment on this. The elegance of the observation occurs before you get into
150

CS
the agonal state, where the exposure of the animal probably has little as anything to do
with what he ultimately gets and dies from.
STANTON: No further comment on that.
J. WARREN: Our firm recently completed a report for OSHA, "The Economic and Infla-
tionary Impact Study for the Effects of a Proposed Standard for Asbestos in Construction,"
and in the process of doing this report for OSHA we had to talk to a lot of your firms,
universities - everybody from environmentalists to producers, maybe not some of you in
here personally. This type of meeting is needed. We need people not just talking to each
other, but with each other, and I think you have seen this today. You got one group over
here saying, "Lookout! we are going to put out of business x number of people." Another
group says you have to protect the worker - the worker comes first even at zero exposure.
The only way we are going to resolve this problem, and it is a very sticky problem, is by
everybody talking together. So that is just a comment; we found there is not enough
talking to each other; even if you don't agree you can still talk. Has anyone looked at
the possibility of using experimental animals other than rats, say a primate? Would this
change results or give better data if we had an animal that would live longer? Has
anyone used a rat that has been exposed to cigarette smoke at the same time?
STANTON: Yes, other species have been used. Dr. Bi11 Smith is here today who has
been using hamsters for many years and has some very elegant data with hamsters. We
ourselves have used mice, and have been successful with mice as well as rats. I don't
think that unless there was an exotic species that we would particularly contribute a
great deal more by using another species. Chickens have been used and various other types
of birds with some interesting results.
